Literature DB >> 15956685

Studies on soluble ectodomain proteins of relaxin (LGR7) and insulin 3 (LGR8) receptors.

Yan Yan1, Jin Cai, Ping Fu, Sharon Layfield, Tania Ferraro, Jin Kumagai, Satoko Sudo, Jian-Guo Tang, Eleni Giannakis, Geoffrey W Tregear, John D Wade, Ross A D Bathgate.   

Abstract

The ectodomains of both the relaxin (LGR7) and the INSL3 (LGR8) receptors can be expressed on the cell surface using only a single transmembrane domain. These membrane-anchored proteins retain the ability to bind relaxin and can be cleaved from the cell surface. The subsequent LGR7 protein, 7BP, binds relaxin and can act as a functional relaxin antagonist. By contrast, the equivalent LGR8 protein 8BP does not bind relaxin or antagonize LGR8 activity. The 7BP protein has been successfully immobilized onto chemically derivatized surfaces for the capture of relaxin peptides and subsequent identification via SELDI-MS analysis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15956685     DOI: 10.1196/annals.1282.007

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  3 in total

Review 1.  Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.

Authors:  M L Halls; E T van der Westhuizen; R A D Bathgate; R J Summers
Journal:  Br J Pharmacol       Date:  2007-02-12       Impact factor: 8.739

2.  Effects of human relaxin on orthodontic tooth movement and periodontal ligaments in rats.

Authors:  Monica S Madan; Zee J Liu; Gao M Gu; Gregory J King
Journal:  Am J Orthod Dentofacial Orthop       Date:  2007-01       Impact factor: 2.650

3.  Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells.

Authors:  Yvonne Radestock; Cuong Hoang-Vu; Sabine Hombach-Klonisch
Journal:  Breast Cancer Res       Date:  2008-08-21       Impact factor: 6.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.